Topoisomerases and tubulin inhibitors: A promising combination for cancer treatment

Current Medicinal Chemistry - Anti-Cancer Agents

Volumn 3, Issue 6, 2003, Pages 421-429

  Rudolf, E ^a   Cervinka M ^a  

^a CHARLES UNIVERSITY   (Czech Republic)

Author keywords

Apoptosis; Cancer treatment; Microtubule poisons; Topoisomerase inhibitors

Indexed keywords

1,2 NAPHTHOQUINONE DERIVATIVE; AMINOACRIDINE DERIVATIVE; ANTHRACYCLINE DERIVATIVE; ANTHRAQUINONE DERIVATIVE; ANTINEOPLASTIC AGENT; CAMPTOTHECIN; CAMPTOTHECIN DERIVATIVE; COLCHICINE; COLCHICINE DERIVATIVE; CYTOSTATIC AGENT; DIDEMNIN B; DISCODERMOLIDE; DNA TOPOISOMERASE INHIBITOR; DOLASTATIN; ELEUTHEROBIN; ETOPOSIDE; FLAVONOID; GEIPARVARIN; HALICHONDRIN B; MAYTANSINE; NAPHTHOQUINONE; PACLITAXEL; PODOPHYLLOTOXIN; PODOPHYLLOTOXIN DERIVATIVE; PROTOBERBERINE DERIVATIVE; TAXANE DERIVATIVE; TUBULIN INHIBITOR; UNCLASSIFIED DRUG; UNINDEXED DRUG; VINBLASTINE; VINCRISTINE;

APOPTOSIS; BONE MARROW SUPPRESSION; CANCER CELL; CANCER COMBINATION CHEMOTHERAPY; CARDIOTOXICITY; CELL CYCLE; CELL DEATH; CELL PROLIFERATION; CYTOSKELETON; DRUG EFFICACY; DRUG MECHANISM; DRUG POTENTIATION; DRUG SYNTHESIS; DRUG TARGETING; HUMAN; MALIGNANT NEOPLASTIC DISEASE; MOLECULAR GENETICS; NONHUMAN; REVIEW; RISK BENEFIT ANALYSIS; SIGNAL TRANSDUCTION; SKIN TOXICITY; TREATMENT OUTCOME;

ANTINEOPLASTIC AGENTS; APOPTOSIS; DNA TOPOISOMERASES; HUMANS; NEOPLASMS; TUBULIN MODULATORS;

EID: 0141919421     PISSN: 15680118     EISSN: None     Source Type: Journal    
DOI: 10.2174/1568011033482242     Document Type: Review

References (131)

1. Miller, A.B. J. Cancer Res. Clin. Oncol. 1991, 117, 177.
2. Bredel, M. Brain Res. Rev. 2001, 35, 161.
3. Daniles, G.A.; Adjei, A.A. Expert Rev. Anticancer Ther. 2001, 1, 211.
4. Oakley, B.O. Trends in Cell Biology 2000, 10, 537.
5. Cassimeris, L.; Spittle, C. Int. Rev. Cytol. 2001, 210, 163.
6. Vallbo, C.; Bergenheim, T.; Hedman, H.; Henriksson, R. J. Neurooncol. 2002, 56, 143.
7. Ho, Y.S.; Duh, J.S.; Jeng, J.H., Wang, Y.J.; Liang, Y.C.; Lin, C.H.; Tseng, C.J.; Yu, C.F.; Chen, R.J.; Lin, J.K. Int. J. Cancer 2001, 3, 393.
8. Levan, A. Hereditas 1938, 24, 471.
9. Wood, K.W.; Cornwell, W.D.; Jacson, J.R. Cur. Opin. Pharmacol. 2001, 1, 370.
10. Hood, K.A.; West, L.M.; Rouwe, B.; Northcote, P.T.; Berridge, M.V.; Wakefield, S.J.; Miller, J.H. Cancer Res. 2002, 62, 3356.
11. Haar, E ter.; Kowalski, R.J.; Hamel, E.; Lin, C.M.; Longley, R.E.; Gunasekera, S.P.; Rosenkrantz, H.S.; Day, B.W. Biochemistry 1996, 35, 243.
12. Bai, R.; Taylor, G.F.; Cichacz, Z.A.; Herald, C.L.; Kepler, J.A.; Pettit, G.R.; Hamel, E. Biochemistry 1995, 34, 9714.
13. Sackett, D.L. Pharmacol. Ther. 1993, 59, 163.
14. Blokhin, A.V.; Yoo, H.D.; Geralds, R.S.; Nagle, D.G.; Gerwick, W.H.; Hamel, E. Mol. Pharmacol. 1995, 48, 523.
15. Petit, G.R.; Herald, C.L.; Boyd, M.R. J. Med. Chem. 1991, 34, 3339.
16. Nicolau, K.C.; Yang, Z.; Liu, J.J. Nature 1994, 367, 630.
17. Roux, F.; Maugras, I.; Poncet, J.; Niel, G.; Jouin, P. Tetrahedron 1994, 50, 5345.
18. Jordan, M.A.; Ojima, I.; Rosas, F.; Distefano, M.; Wilson, L.; Scambia, G.; Ferlini, C. Chemistry & Biology 2002, 9, 93.
19. Uckun, F.M.; Mao, Ch.; Vassilev, A.O.; Huang, H.; Jan, S-T. Bioorg. & Medic. Chem. Lett. 2000, 10, 541.
20. Jordan, M.A. Curr. Med. Chem. - Anti-Cancer Agents 2002, 1, 1.
21. Kavallaris, M.; Verrills, N.M.; Hill, B.T. Drug Resist. Updat. 2001, 4, 392.
22. Iwasaki, S. Yakugaku Zasshi 1998, 118, 112.
23. Horwitz, S.B.; Trends in Pharmacol. Sci. 1992, 13, 134.
24. Derry, W.B.; Wilson, L.; Jordan, M.A. Biochemistry 1995, 34, 2203.
25. Correia, J.J.; Lobert, S. Curr. Pharm. Des. 2001, 7, 1213.
26. Yvon, A.-M.; Wadsworth, P.; Jordan, M.A. Mol.Biol. Cell. 1999, 10, 947.
27. Downing, K.H. Annu. Rev. Cell Dev. Biol. 2000, 16, 89.
28. Chen J.G.; Horwitz, S.B. Cancer Res. 2002, 62, 1935.
29. Mekhail, T.M.; Markman, M. Expert Opin. Pharmacother. 2002, 3, 755.
30. Hait, W.N.; Rubin, E.; Goodin, S. Cancer Chemother. Biol. Response Modif. 2001, 19, 59.
31. Drukman, S.; Kavallaris, M. Int. J. Oncol. 2002, 21, 621.
32. Michaud, L.B.; Valero, V.; Hortobagyi, G. Drug Saf. 2000, 23, 401.
33. Polizzi, D.; Pratesi, G.; Tortoreto, M.; Supino, R.; Riva, A.; Bombardelli, E., Zunino, F. Cancer Res. 1999, 59, 1038.
34. Smith, C.D.; Zhang, X.; Mooberry, S.L., Patterson, G.M.L.; Moore, R.E. Cancer Res. 1994, 54, 3779.
35. Wartmann, M.; Altman, K.-H. Curr. Med. Chem. - Anti-Cancer Agents 2002, 1, 123.
36. Wassmann, K.; Benezra, R. Curr. Opin. Genet. Dev. 2001, 11, 83.
37. Kallio, M.; Sjoblom, T.; Lahdetie, J. Environ. Mol. Mutagen. 1995, 25, 106.
38. Jordan, M.A.; Thrower, D.; Wilson, L. J. Cell. Sci. 1992, 102, 401.
39. Irving, J.A.; McFarland, D.F.; Stuart, D.S.; Gilks, C.B. Int. J. Gynecol. Pathol. 2000, 19, 395.
40. Jordan, M.A.; Wendell, K.; Gardiner, S.; Derry, W.B.; Copp, H.; Wilson, L. Cancer Res. 1996, 56, 816.
41. Tseng; C.J.; Wang, Y.J.; Liang, Y.C.; Jeng, J.H.; Lee, W.S.; Lin, J.K.; Chen, C.H.; Liu, I.C.; Ho, Y.S. Toxicology 2002, 175, 123.
42. Tsuchida, T.; Yoshimura, K.; Shirayama, Y.; Kawamoto, K. Cytometry 1998, 31, 295.
43. Lieu, CH.; Chang, Y.N; Lai; Y.K.Biochem. Pharmacol. 1997, 53, 1587.
44. Gallaher, B.W.; Berthold, A.; Klammt, J.; Knupfer, M.; Kratzsch, J.; Bartsch, M.; Kiess, W. Cell. Mol. Biol. 2000, 46, 79.
45. Mooberry, S.L.; Busquets, L.; Tien, G. Int. J. Cancer 1997, 73, 440.
46. André, N.; Braguer, D.; Brasseur, G.; Goncalves, A.; Lemesle-Meunier, D.; Guise, S.; Jordan, M.A.; Briand, C. Cancer Res. 2000, 60, 5349.
47. Yoshida, D.; Hoshino, S.; Shimura, T.; Takahashi, H.; Teramoto, A. J. Neurooncol. 2000, 47, 133.
48. Huisman, C.; Ferreira, C.G.; Broker, L.E.; Rodriguez, J.A.; Smit, E.F.; Postmus, P.E.; Kruyt, F.A.; Giaccone, G. Clin. Cancer Res. 2002, 2, 596.
49. Broker, L.E.; Huisman, C.; Ferreira, C.G.; Rodriguez, J.A.; Kruyt, F.A.; Giaccone, G. Cancer Res. 2002, 62, 4081.
50. Wang, L.G.; Liu, X.M.; Kreis, W.; Budman, D.R. Cancer Chemother. Pharmacol. 1999, 44, 355.
51. Blagosklonny, M.V.; Giannakakou, P.; el-Deiri, W.S.; Kingston, D.G.; Higgs, P.I.; Neckers, L.; Fojo, T. Cancer Res. 1997, 57, 130.
52. Jan, S-T; Mao, Ch; Vassilev, A.O.; Navara, Ch.S.; Uckun, F.M. Bioorg. & Medic. Chem. Lett. 2000, 10, 1193.
53. Dumontet, C.; Sikic, B.I. J. Clin. Oncol. 1999, 3, 1061.
54. Sangrajrang, S.; Fellous, A. Chemotherapy 2000, 46, 327.
55. Rowinsky, E.K.; Donehower, R.C. Pharmacol. Ther. 1991, 52, 35.
56. Ali, S.; Ahmad, I.; Peters, A.; Masters, G.; Minchey, S.; Janoff, A.; Mayhew, E. Anticancer Drugs 2001, 2, 117.
57. Distefano, M.; Scambia, G.; Ferlini, C.; Gallo, D.; De Vincenzo, R.; Filippini, P.; Riva, A.; Bombardelli, E.; Mancuso, S. Anticancer Drug Des. 1998, 13, 489.
58. Ferlini, C.; Distefano, M.; Pignatelli, F.; Lin, S.; Riva, A.; Bombardelli, E.; Mancuso, S.; Ojima, I.; Scambia, G. Br. J. Cancer 2000, 12, 1762.
59. Ehlert, J.E.; Kubbutat, M.H. Onkologie 2001, 24, 433.
60. Zornig, M.; Hueber, A.; Baum, W.; Evan, G. Biochim. Biophys. Acta 2001, 1551, F1.
61. Jiang, J.D.; Denner, L.; Ling, Y.H.; Li, J.N.; Davis, A.; Wang, Y.; Li, Y.; Roboz, J.; Wang, L.G.; Perez-Soler, R.; Marcelli, M.; Bekesi, G.; Holland, J.F. Cancer Res. 2002, 21, 6080.
62. Holden, J.A. Curr. Med. Chem. - Anti-Cancer Agents 2001, 1, 1.
63. Champoux, J.J. Annu. Rev. Biochem. 2001, 70, 369.
64. Wang, J.C. Nat. Rev. Mol. Cell Biol. 2002, 3, 430.
65. Yang, X.; Li, W.; Prescott, E.D.; Burden, S.J.; Wang, J.C. Science 2000, 287, 131.
66. Beck, W.T. In Principles of Cancer Drug Pharmacology; Shilsky, R.; Milano, G.; Ratain, M; Eds.; Marcel Decker: New York, 1996; pp. 487-501.
67. Bailly, C. Curr. Med. Chem. 2000, 7, 39.
68. Fortune, J.M. Prog. Nucl. Acid Res. 2000, 64, 221.
69. Plyta, Z.F.; Li, T.; Papageorgiou, V.P.; Mellidis, A.S.; Assimopoulou, A.N.; Pitsinos, E.N.; Couladouros, E.A. Bioorg. Med. Chem. Lett. 1998, 8, 3385.
70. Dolan, M.E.; Frydman, B.; Thompson, C.B.; Diamond, A.M.; Garbiras, B.J.; Safa, A.R.; Beck, W.T.; Marton, L.J. Anticancer Drugs 1998, 9, 437.
71. Gatto, B.; Sanders, M.M.; Yu, C.; Wu, H.; Makhley, D.; LaVoie, E.J.; Liu, L.F. Cancer Res. 1996, 56, 2795.
72. Kim, D.K.; Lee, N. Mini Rev. Med. Chem. 2002, 2, 611.
73. Pantazis, P.; Kozielski, A.; Rodriguez, R.; Petry, E.; Wani, M.; Wall, M.; Giovanella, B. Melanoma Res. 1994, 4, 5.
74. Morris, E.J.; Geller, H.M. J. Cell Biol. 1996, 134, 757.
75. Yoshida, A.; Ueda, T.; Wano, Y.; Nakamura, T. Jpn. J. Cancer Res. 1993, 84, 566.
76. Chatterjee, D.; Wyche, J.H.; Pantazis, P. Anticancer Res. 2000, 20, 4477.
77. Agarwal, M.L.; Taylor, W.R.; Chernov, M.V.; Chernova, O.B., Stark, G.R. J. Biol. Chem. 1998, 1, 1.
78. Boege, F.; Straub, T.; Kehr, A.; Bosenberg, C.; Christiansen, K.; Anderson, A.; Jacob, F.; Kohrle, J. J. Biol. Chem. 1996, 271, 2262.
79. Chowdhury, A.R.; Sharma, S.; Mandal, S.; Goswami, A.; Mukhopadhyay, S.; Majumder, H.K. Biochem. J. 2002, 366, 653.
80. Liu, L.F. Ann. Rev. Biochem. 1989, 58, 351.
81. Nitiss, J.L. Curr. Opin. Investig. Drugs 2002, 3, 1512.
82. Willmore, E.; Errington, F.; Tilby, M.J.; Austin, C.A. Biochem. Pharmacol. 2002, 63, 1807.
83. Popov, I.; Jelic, S.; Radosavljevic, D.; Nikolic-Tomasevic, Z. Eur. Urol. 2001, 40, 324.
84. Crepsi, M.O.; Ivanier, S.E.; Genovese, J. Biochem. Biophys. Res. Comm. 1986, 136, 521.
85. Lurain, J.R. Curr. Treat. Options Oncol. 2002, 3, 113.
86. Krishnan, P.; Bastow, K.F. Anti-Cancer Drug Design 2000, 15, 255.
87. Bastow, K.F.; Itoigawa, M.; Furukawa, H.; Kashiwada, Y.; Bori, I.D.; Ballas, L.M.; Lee, K.H. Bioorg. Med. Chem. 1994, 2, 1403.
88. Drake, F.H.; Hofmann, G.A.; Mong, S.M.; Bartus, J.O.; Hertzberg, R.P.; Johnson, R.K.; Mattern, M.R.; Mirabelli, C.K. Cancer Res. 1989, 49, 2578.
89. Wessel, I.; Jensen, L.H.; Jensen, P.B.; Falck, J.; Rose, A.; Roerth, M.; Nitiss, J.L.; Sehested, M. Cancer Res. 1999, 59, 3442.
90. Krishnan, P.; Bastow, K.F. Cancer Chemother. Pharmacol. 2001, 47, 187.
91. Karpinich, N.O.; Tafani, M.; Rothman, R.J.; Russo, M.A.; Farber, J.L. J. Biol. Chem. 2002, 277, 16547.
92. Wang, X. Genes & Development 2001, 15, 2922.
93. Cervinka, M.; Bereiter-Hahn, J.; Peychl, J.; Rudolf, E.; Cervinkova, Z. Gen. Physiol. Biophys. 1999, 18 Spec No:33.
94. Dent, P.; Grant, S. Clin. Cancer Res. 2001, 7, 775.
95. Das, U. Med. Sci. Monit. 2002, 8, RA 79.
96. Boland, M.P. Biochem. Soc. Trans. 2001, 29, 674.
97. Mo, Y.Y.; Beck, W.T. Mol. Pharmacol. 1999, 55, 216.
98. Broomberg, J. F. Bioessays 2001, 23, 161.
99. Kiyomiya, K-I.; Kurebe, M.; Nakagawa, H.; Matsuo, S. Int. J. Onc. 2002, 20, 1205.
100. Beck, W.T.; Mo, Y.Y.; Bhat, U.G. Biochem. Soc. Trans. 2001, 29, 702.
101. Fattman, C.L.; Delach, S.M.; Dou, Q.P.; Johnson, D.E. Oncogene 2001, 20, 2918.
102. Etiévant, C.; Kruczynski, A.; Barret, J.M.; Perrin, D.; van Hille, B.; Guminski, Y.; Hill, B.T. Cancer Chemother. Pharmacol. 2000, 46, 101.
103. Parajuli, P.; Yano, S.; Nishioka, Y.; Nokihara, H.; Hanibuchi, M.; Nishimura, N.; Utsugi, T.; Sone, S. Oncol. Res. 1999, 11, 219.
104. Nowell, P.C. Science 1976, 194, 23.
105. Hirose, M. Int. J. Hematol. 2002, Suppl 2, 206.
106. Herzog, T.J. Oncologist 2002, 7 Suppl 5, 3.
107. Li, Y.; McClay, E.F. Semin. Oncol. 2002, 29, 413.
108. Fromm, M.F. Adv. Drug Deliv. Rev. 2002, 54, 1295.
109. Ikeda, T.; Jinno, H.; Matsu, A.; Masamura, S.; Kitajima, M. Breast Cancer 2002, 9, 8.
110. Smorenburg, C.H.; Sparreboom, A.; Bontenbal, M.; Verweij, J. Eur. J. Cancer 2001, 37, 2310.
111. Michaud, L.B.; Valero, V.; Hortobagyi, G. Drug Saf. 2000, 23, 401.
112. Shang, X.; Shiono, Y.; Fujita, Y.; Oka, S.; Yamazaki, Y. Anticancer Res. 2001, 21, 2585.
113. Majlessipour, F.; Avramis, I.A.; Kwock, R.; Weinberg ,K.I.; Avrami, V.I. Anticancer Res. 2002, 22, 1361.
114. Chou, T.C.; Motzer, R.J.; Tong, Z.; Bosl, G.J. J. Natl. Cancer. Inst. 1994, 86, 1517.
115. Jonsson, E.; Fridborg, H.; Nygren, P.; Larsson, R. Eur. J. Clin. Pharmacol. 1998, 54, 509.
116. Lundberg, B.B. Anticancer Drug Des. 1997, 12, 503.
117. Kaufmann, S.H.; Peereboom, D.; Buckwalter, C.A.; Svingen, P.A.; Grochow, L.B.; Donehower, R.C.; Rowinsky, E.K. J. Natl. Cancer Inst. 1996, 88, 734.
118. Schmidt, F.; Schuster, M.; Streffer, J.; Schabet, M.; Weller, M. Anticancer Res. 1999, 19, 1217.
119. Huang, T.S.; Shu, CH.; Chao, Y.; Chen, L.T. Anticancer Drugs 2001, 12, 259.
120. Perez, E.A.; Buckwalter, CH.A. Cancer Chemother. Pharmacol. 1998, 41, 448.
121. Bahadori, H.R.; Green, M.R.; Catapano, C.V. Cancer Chemother. Pharmacol. 2001, 48, 188.
122. Arimondo, P.; Boukarim, CH.; Bailly, CH.; Dauzonne, D.; Monneret, C. Anti-Cancer Drug Design 2000, 15, 413.
123. Finlay, G.J.; Atwell, G.J.; Baguley, B.C. Oncology Research 1999, 11, 249.
124. Yoshimatsu, K.; Yamaguchi, A.; Yoshino, H.; Koyanagi, N.; Kitoh, K. Cancer Res. 1997, 57, 3208.
125. Dutcher, J.P.; Novik, Y.; O'Boyle, K.; Marcoullis, G.; Secco, C.; Wiernik, P.H. J. Clin. Pharmacol. 2000, 40, 1079.
126. Konig, E.; Kurbacher, C.; Schwonzen, M.; Breidenbach, M.; Mallmann, P. Anticancer Drugs 2002, 13, 827.
127. Masuda, N.; Negoro, S.; Kudoh, S.; Sugiura, T.; Nakagawa, K.; Saka, H.; Takada, M.; Niitani, H.; Fukuoka, M. J. Clin. Oncol. 2000, 18, 2996.
128. Tartarone, A.; Sirotova, Z.; Aieta, M., Lelli, G. Tumori 2001, 87, 134.
129. Melichar, B.; Touskova, M.; Dvorak, J.; Jandik, P.; Kopecky, O. Immunopharmacology and Immunotoxicology 2001, 23, 163.
130. Fung, H.C.; Nademanee, A.P. Hematol. Oncol. 2002, 20, 1.
131. Waters, J. S.; O'Brien, M.E. Br. J. Cancer 2002, 87, 481.